Predicting bacteremia and bacteremic mortality in liver transplant recipients

Liver Transplantation

Volumn 6, Issue 1, 2000, Pages 54-61

  Singh, Nina ^a,b   Paterson, David L ^a   Gayowski, Timothy ^a   Wagener, Marilyn M ^a   Marino, Ignazio R ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BILIRUBIN;

ALBUMIN BLOOD LEVEL; ARTICLE; BACTEREMIA; BILIRUBIN BLOOD LEVEL; BLOOD PRESSURE; BODY TEMPERATURE; DIABETES MELLITUS; HUMAN; INTENSIVE CARE UNIT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; RISK FACTOR;

EID: 0034048969     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.500060112     Document Type: Article

References (34)

1. Lumbreras C, Lizasoain M, Moreno E, Agaudo JM, Gomez R, Garcia I, et al. Major bacterial infections following liver transplantation. Hepatogastroenterology 1992;39:362-365.
2. Mora P, Gonwa TA, Goldstein R, Husberg BS, Klintmalm GB. Risk factors of postoperative infection after liver transplantation: A univariate and stepwise logistic regression analysis of risk factors in 140 consecutive patients. Clin Transplant 1992;46:443-449.
3. Kusne S, Dummer JS, Singh N, Iwatsuki S, Makowka L, Esquivel C, et al. Infections after liver transplantation, an analysis of 101 consecutive cases. Medicine 1988;67:132-143.
4. Singh N, Gayowski T, Wagener M, Yu VL. Infectious complications in liver recipients on tacrolimus: Prospective analysis of 88 consecutive liver transplants. Transplantation 1994;58:774-778.
5. Wagener MM, Yu VL. Bacteremia in transplant recipients: A prospective study of demographics, etiologic agents, risk factors, and outcomes. Am J Infect Control 1992;20:239-247.
6. George DL, Arnow PM, Fox AS, Baker AL, Thistlewaite JR, Emond JC, et al. Bacterial infection as a complication of liver transplantation: Epidemiology and risk factors. Rev Infect Dis 1991;13:387-396.
7. Wade JJ, Rolando N, Hallar K, Philpott-Howard J, Casewell MW, Williams R. Bacterial and fungal infections after liver transplantation: An analysis of 284 patients. Hepatology 1995; 21:1328-1366.
8. Singh N, Gayowski T, Wagener MM, Marino IR. Predictors and outcome of early versus late-onset major bacterial infections in liver transplant recipients receiving tacrolimus (FK506) as primary immunosuppression. Eur J Clin Microbiol Infect Dis 1997;16:821-826.
9. Bates DW, Cook EF, Goldman L, Lee TH. Predicting bacteremia in hospitalized patients, a prospectively validated model. Ann Intern Med 1990;113:495-500.
10. Mellors JW, Horwitz RI, Harvey MR, Horwitz SM. A simple index to identify occult bacterial infection in adults with acute unexplained fever. Am J Med 1987;147:666-671.
11. Singh N, Yu VL, Mieles L, Wagener MM, Miner RC, Gayowski T. High-dose acyclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients, a randomized trial. Ann Intern Med 1994;120:375-381.
12. Chang FY, Singh N, Gayowski T, Wagener MM, Marino IR. Fever in liver transplant recipients in the 1990s: Changing spectrum of etiologic agents. Clin Infect Dis 1998;26:59-65.
13. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions of nosocomial infections. Am J Infect Control 1988;16:128-140.
14. Singh N, Gayowski T, Wagener MM, Marino IR, Yu VL. Pulmonary infections in liver transplant recipients receiving tacrolimus. Transplantation 1996;61:396-401.
15. Singh N, Carrigan DR, Gayowski T, Marino IR. Human herpesvirus-6 infection in liver transplant recipients: Documentation of pathogenicity. Transplantation 1997;64:674-678.
16. Singh N, Gayowski T, Wagener MM. Intensive care unit management in liver transplant recipients: Beneficial effect on survival and preservation of quality of life. Transplantation 1997;11:113-117.
17. Singh N, Zeevi A, Gayowski T, Marino IR. Late-onsetcytomegalovirus disease in liver transplant recipients; De novo reactivation in recurrent viral HCV hepatitis. Transpl Int 1998;11:308-311.
18. Arbo MJ, Fine MJ, Hanusa BH, Sefcik T, Kapoor WN. Fever of nosocomial origin: Etiology, risk factors, and outcomes. Am J Med 1993;95:505-512.
19. Bor DH, Makadon HJ, Friedland G, Dasse P, Komaroff AL, Aronson MD. Fever in hospitalized medical patients: Characteristics and significance. J Gen Intern Med 1988;3:119-125.
20. Pittet D, Thievent B, Wenzel RP, Li N, Auckenthales R, Suter PM. Bedside prediction of mortality from bacteremic sepsis, a dynamic analysis of ICU patients. Am J Respir Crit Care Med 1996;153:684-693.
21. Weinstein MP, Murphy JR, Relier LB, Lichtenstein KA. The clinical significance of positive blood cultures: A comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. Clinical observations with special reference factors influencing prognosis. Rev Infect Dis 1983;5:54-70.
22. Weinstein MP, Iannini PB, Stratton CW, Eckhoff TC. Spontaneous bacterial peritonitis, a review of 18 cases with emphasis on improved survival and factors influencing prognosis. Am J Med 1978;64:592-598.
23. Bryant RE, Hood AF, Hood CE, Koenig MG. Factor affecting mortality of gram-negative rod bacteremia. Arch Intern Med 1987;147:666-671.
24. Kluger MJ, Ringler DH, Anver MR. Fever and survival. Science 1975;188:166-168.
25. Hasday JD. The influence of temperature on host defenses. In: Mackowiak PA (ed). Fever: Basic mechanisms and management (ed 2). Philadelphia: Lippincott-Raven, 1997:177-196.
26. Mackowiak PA, Browne RH, Southern PM Jr, Smith JW. Polymicrobial sepsis: An analysis of 184 cases using log linear models. Am J Med Sci 1980;280:73-80.
27. 2 consumption of human polymorphonuclear leukocytes. J Reticuoendothel 1980;27:561-565-
28. Bryant RE, DesPrez RM, VanWay MH, Rogers DE. Studies on human leukocyte motility. I. Effects of alterations in pH, electrolyte concentration, and phagocytosis on leukocyte migration, adhesiveness, and aggregation. J Exp Med 1966;124:483-499.
29. van Dijk H, Rademaker PM. Infectious disease, fever and the immune response. Immunol Today 1977;29:464-467.
30. Mackowiak PA, Marling-Cason M. Hyperthermic enhancement of serum antimicrobial activity: Mechanism by which fever might exert a beneficial effect on the outcome of gram-negative sepsis. Infect Immun 1983;39:38-42.
31. Mackowiak PA, Marling-Cason M, Cohen RL. Effects of temperature on antimicrobial susceptibility of bacteria. J Infect Dis 1982;145:550-553.
32. Dismukes WE, Cloud G, Gallis HA, Kerkering TM, Mwsodd F, Craven PC, et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N Engl J Med 1987;317:334-341.
33. Fine MJ, Orloff JJ, Arisumi D, Fang G, Arena VC, Hanusa BH, et al. Prognosis of patients hospitalized with community-acquired pneumonia. Am J Med 1990;88:51-58.
34. Research Committee of the British Thoracic Society and the Public Health Laboratory Service. Community-acquired pneumonia in adults in British hospitals in 1982-1983: A survey of aetiology, mortality, prognostic factors, and outcome. QJ Med 1987;62:195-222.